INVO Bioscience

INVO • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $1,381 $1,381 $974 $315
Gross Profit 495 495 393 60
EBITDA -1,395 -873 -2,062
EBIT -1,536 -894 -2,024
Net Income -1,994 -1,994 -1,248 -2,240
Net Change In Cash 1,381 1,381 974 315
Free Cash Flow -789 -789 -1,355 -1,905
Cash 232 232 1,055 112
Basic Shares 1,565 2,492 1,776 732

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $3,020 $822 $4,160 $1,037
Gross Profit 1,086 490 4,015 948
EBITDA -6,626 -10,826 -5,374 -5,510
EBIT -6,827 -10,626 -5,216 -5,514
Net Income -8,034 -10,892 -6,654 -8,347
Net Change In Cash 3,020 822 4,160 1,037
Free Cash Flow -5,199 -6,616 -6,484 -4,864
Cash 232 90 5,684 10,097
Basic Shares 1,565 606 531 274

Earnings Calls

Quarter EPS
2024-03-31 -$0.80
2023-09-30 -$0.70
2023-06-30 -$3.06
2023-03-31 -$0.23